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Simple Summary: Vocal nodules, together with vocal polyps, are the most common benign vocal 
cord structures that are thought to be caused by extensive vocal abuse (shouting, talking loudly for 
prolonged periods) and are routinely treated surgically. However, surgical excision of these nodules, 
does not exclude the possibility of recurrence of these nodules, especially if lifestyle changes are not 
adapted to prevent phonetic trauma. Furthermore, the etiopathogenetic pathways governing the for-
mation and maintenance of these nodules are not known. Herein, we investigated the etiopathogenetic 
markers for proliferation, apoptosis, growth, ischemia (tissue hypoxia), inflammation and innervation to 
elucidate the causative pathways. We found a profound and significant intensification of apoptosis in 
tissue epithelium, which strongly correlated with proliferative, ischemic, and inflammatory changes, 
highlighting the underlying complex interactions between various mechanisms on a cellular and 
tissue level, which occur during the morpho-pathogenesis of vocal nodules. 
Abstract: Vocal nodules (or Singer’s nodules) are benign vocal cord structures which are commonly 
encountered by clinicians. Though phonetic trauma/abuse is thought to be the main cause of the 
development of vocal nodules, the exact etiopathogenesis remains unknown. Hence, we compared 
the immunohistochemical markers for proliferation (Ki-67), apoptosis (TUNEL), growth (EGFR), 
ischemia (VEGF), inflammation (IL-1α and 10), and immunoreactive innervation (PGP 9.5), in vocal 
nodule tissue samples obtained from 10 females (17–56 years) and vocal cord tissue from seven 
controls. A statistically significant increase in Ki-67, TUNEL, EGFR, VEGF and IL-1α expression 
was noted (p < 0.05) between nodule tissue and control tissue in both epithelial and subepithelial 
layers. However, the difference was non-significant for both IL-10 and PGP 9.5 (p > 0.05). All mark-
ers demonstrated moderate to strong positive correlations, except for IL-10. These findings suggest 
increased cellular growth and proliferation in vocal nodules coupled with a persistent presence of 
inflammatory and ischemic environment. Furthermore, global prevalence of apoptotic cells and de-
creased anti-inflammatory cytokines highlight the presence of underlying complex mechanisms in 
the etiopathogenesis of vocal nodules, with age having a negligible impact on the marker levels. 
Our results could potentially further our knowledge in understanding the effects of different treat-
ment modalities available at the cellular level. 
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Neoplastic structures of the vocal cords are divided into malignant and benign le-
sions. Clinically, the most common benign masses/lesions of the vocal fold are polyps, 
nodules, Reinke’s oedema, and cysts, and are thought to be due to phonetic trauma [1]. 
The presence of vocal noduli in the larynx leads to increased friction of the vocal cords 
against each other, thereby raising the circumscribed hyperplastic changes and/or hyper-
keratinisation of the epithelial layer, coupled with secondary hyaline-degeneration in the 
lamina propria of the vocal cords. Vocal noduli, together with vocal polyps, are caused by 
extensive vocal abuse (shouting, talking loudly for prolonged periods) and are routinely 
treated surgically [2]. However, surgical excision of these nodules does not exclude the 
possibility of their recurrence, especially if lifestyle changes are not adapted to prevent 
phonetic trauma. 
Previously, multiple studies have been reported that describe the routine histomor-
phology of the vocal noduli, however, most of them lack a specific description or explo-
ration of the various possible morpho-pathogenetic events that might be involved in the 
development and maintenance of vocal noduli, such as proliferative, programmed cell 
death, growth, ischemic, inflammatory, and neuropeptide-containing innervation path-
ways and proteins. Under physiological conditions, the tissue of the vocal box is con-
stantly undergoing renewal and regenerative processes due to the permanent stress it en-
dures while producing voice. Moreover, the rate and intensity of these processes in the 
tissue depend upon a person’s functional intensity of their vocal apparatus, with more 
frequent and abusive use accelerating these processes. 
The main proliferation marker used for histomorphological analysis is the human Ki-
67, an antigen encoding two related protein isoforms. The Ki-67 protein is present in all 
active stages of a cell cycle (G1, S, G2, M), but is absent in the non-active stages (G0) [3,4]. 
Thus, it is an extremely reliable and useful marker for determining the growth fraction of 
a cell population and is often used as an indicator for proliferation intensity, for example, 
to estimate a tumour’s proliferation index [5]. Consequently, an even more prognostic 
value for the marker is evident in various neoplasms of the soft tissue, breast, lung, pros-
tate, cervix, and central nervous system [6–9]. Though the marker is extensively employed 
in oncology, its expression in the healthy vocal cord tissue and benign structures has been 
studied in a limited context. 
Several voice disorders have been shown to be associated with the process of apop-
tosis or programmed cell death. The most common of such epithelium-associated apop-
totic processes are described in the context of laryngeal squamous cell carcinoma, leuco-
plakia, keratosis, epithelial hyperplasia, human papilloma virus (HPV) papilloma and few 
other benign lesions. Hence, this leads us to speculate that apoptotic cell death may at 
least partly contribute to the pathogenesis of diseases affecting the vocal fold epithelium 
[10]. Additionally, apoptosis has been described in the laryngeal epithelium in response 
to the physical stressors of abduction, adduction, and biochemical vibrations. The authors 
reported the persistence of a moderate number of apoptotic cells, whilst a slower cellular 
turnover was described, for instance, during the immobilization of vocal folds [10]. Inter-
estingly, by evaluation of the apoptotic index in the vocal fold polyps, a higher apoptotic 
index was established in another study. The authors further reported simultaneous inten-
sification of mitotic divisions, inflammation, and exocytosis when compared with the nor-
mal epithelium of the vocal folds [11]. However, the calculations of the apoptotic index 
and, in general, the apoptotic process in the case of vocal cord nodules, have not been 
established until now. 
The development of vocal cord nodules is usually stimulated by the intensification 
of the local blood supply and associated local stimulating factors. To these factors belongs 
the vascular endothelial growth factor (VEGF), an angiogenic factor described as one of 
the most important and critical growth factors required for neoangiogenesis in the vascu-
lar endothelial cells. VEGF is produced by many cell types including tumour cells, mac-
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rophages, platelets, keratinocytes, renal mesangial cells, and is commonly seen upregu-
lated in many tumours where it strongly supports tumour angiogenesis and survival. 
Apart from playing a role in the vascular system, VEGF is also active during multiple 
normal physiological and homeostatic processes such as bone formation (osteogenesis), 
haematopoiesis, wound healing, and development [12]. In case of tissue trauma or inflam-
mation, different cell types can release VEGF, with tissue hypoxia or ischemic changes 
being one of its most potent inducers. In other words, hypoxia can regulate the cellular 
responses and, in turn, VEGF expression [13]. However, the role of such hypoxic condi-
tions in vocal nodules has not been described. 
Interleukin-1 (IL-1) is a member of a family of 11 interleukins, whereby IL-1 has been 
described to be the most potent and persistent interleukin in the settings of acute and 
chronic inflammations. In human diseases, IL-1 mediates the inflammatory processes by 
binding to the ligand-binding chain of its dedicated receptor (IL-1RI), leading to the acti-
vation of a co-receptor chain (IL-1RAcP) and the formation of a complex (IL-1RI–IL-1–
coreceptor). The release of IL-1 is considered as a multifactorial process [14], under the 
control of multiple local and systemic factors. The release of IL-1 and prostaglandin E2 
(PGE-2) in response to vocal cord injuries has been described in a rabbit model. Injuries 
of the vocal fold epithelium led to the release of both mediators. The concentration of both 
inflammatory mediators was reported by the authors at six different time points after lar-
yngeal vocal fold injury using enzyme-linked immunosorbent assay (ELISA). The re-
leased mediators behaved in a predictable and comparable fashion to other controlled 
injury tissues, thereby suggesting that the surface secretions of these mediators from the 
vocal folds can serve as potential indicators of wound healing processes [15]. 
This illustrated that IL-1 as a histological marker, can be used in the same way as it 
is used for evaluation of other tissue specimens from the human body. Furthermore, IL-1 
mediated inflammation can lead to scar formation, collagen deposition and, in most prob-
abilities, also to the formation of vocal cord noduli. Vocal fold nodules contain a fibrin 
matrix organized with other matrix proteins, including collagen, and demonstrate prom-
inent tissue fibrosis [16]. So, the composition of collagen tissue could deliver traces of the 
origin of the vocal cord nodule and answer the question if IL-1 is/was histologically pre-
sent in the vocal noduli to mediate the pathogenesis of formation of vocal cord noduli. 
One of the strongest anti-inflammatory cytokines, IL-10, was found to be increased 
significantly during wound-healing, stimulating acupuncture after phono-traumatic vo-
cal fold lesions [17], with prominent expression observed also in the cases of acute vocal 
cord injury [18]. Moreover, IL-10 might be of particular interest in determining the prog-
nosis of vocal cord leucoplakia as it is related to malignancy [19], but its expression in 
healthy vocal cords and tissue affected by vocal noduli is still not known. Another rather 
more interesting issue is the innervation of the vocal cord tissue that can change in differ-
ent circumstances such as inflammation under the influence of various environmental fac-
tors. The rich presence of general neuroendocrine markers in the human nasal mucosa, 
soft palate, and the larynx [20] makes evaluating the neuropeptide-containing innervation 
in vocal noduli quite intriguing. Furthermore, other reports have described such nerve 
endings related research only in animals [21,22] and, hence, nothing is known about the 
changes of immunoreactive innervation in benign human vocal cord structures. 
The epidermal growth factor receptor (EGFR) is a transmembrane growth factor re-
ceptor protein, which directs the behaviour of epithelial cells and tumour cells of epithelial 
origin. Several types of cancers demonstrate overexpression of EGFR due to the presence 
of a higher amplitude and frequency of its signalling. This allows the cells to proliferate 
much faster, aggressively, and more invasively. Therefore, an increased level of EGFR, 
especially in tumour cells, is connected to a poor prognosis and reduced life expectancy 
[23]. Since the region of the vocal box is constantly under stress for sound production, the 
EGFR and related tissue growth was specifically evaluated in a study associated with ne-
oplasms during squamous cells carcinogenesis. In the study, the authors obtained speci-
mens that ranged from normal to hyperplastic lesions with no atypia, low-grade atypia, 
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and high-grade atypia. The authors reported that low and high-grade dysplasia had 
higher EGFR immunopositive cells compared to normal epithelium and simple hyper-
plasia. Furthermore, they established a direct positive trend between EGFR expression 
and the grade of the tumour [24]. 
Another study revealed that the vocal cord polyps demonstrate hyperplasia in 
50.75% of the investigated cases, as against 82.14% in cases of vocal cord nodules [25]. At 
the same time, the study reported that 31.34% of polyps show atrophic changes, whilst 
12.5% of vocal nodules showed such changes [25]. Generally, since the EGFR is referred 
to as the most important diagnostic marker in dysplastic changes, it becomes essential to 
also detect EGFR expression in normal vocal cord nodules. On the basis of the above pre-
sented points, the aim of our present work was to investigate the etiopathogenetic mark-
ers for proliferation, programmed cell death (apoptosis), growth, ischemia, inflammation, 
and immunoreactive innervation in the vocal cord noduli and normal vocal cord tissue 
(controls), and elucidate their possible involvement in the morpho-pathogenesis of this 
frequently reported clinically benign disease. 
2. Materials and Methods 
2.1. Patient Material Collection 
Tissue samples from vocal nodules were obtained from 10 female patients who un-
derwent surgical treatment. The females were aged between 17 and 56 years. Patient in-
clusion criteria were: (i) Diagnosis of chronic hyperplastic laryngitis with presence of vo-
cal nodule; (ii) Absence of any other larynx pathology and (iii) No past/current use of 
medications or other treatment modalities, including previous surgeries in laryngeal re-
gion. Patient exclusion criteria included: (i) Refusal to participate in the study; (ii) Known 
respiratory oncological diseases, especially in larynx and (iii) Newly diagnosed or pre-
oncological lesion of the respiratory tract. 
The 10 female patients who were enrolled in the present study reported hoarseness 
in the voice for more than two weeks and were involved in voice-intensive jobs such as 
teaching, professional singing, etc. The patients had no significant medical history prior 
to this and were completely healthy. They did not visit the doctor and waited for the 
hoarseness to disappear on its own. However, when the symptoms did not improve after 
two weeks, they paid their first-ever visit to the ENT clinic, where the diagnosis of vocal 
noduli was provided. None of the patients were smokers, had gastroesophageal reflux 
disease (GERD), or any other causative aetiology for vocal noduli except voice abuse. All 
patients were treated in the outpatient department of the clinic and did not underwent 
any voice therapy. Additionally, control tissue was obtained from vocal cords of seven 
cadavers (aged 40–70 years) stored in the tissue collection at the Department of Morphol-
ogy, Riga Stradins University (RSU). 
2.2. Ethical Approval 
The present study was conducted at the Department of Otorhinolaryngology and 
Department of Morphology of Riga Stradins University (RSU) between 2019 and 2020. 
The study protocol was approved by the local ethics committee of the Riga Stradins Uni-
versity (dated 31.10.2019 vide no.6–2/9/25). All the patients or parents of patients gave 
their informed consent to participate in the study. The nature of the study had been fully 
explained to the patients and parents of the patients. 
2.3. Routine Staining and Immunohistochemistry 
All collected tissue samples were fixed in a mixture of 2% formaldehyde and 0.2% pic-
ric acid in 0.1 M phosphate buffer (pH 7.2) and rinsed in Tyrode buffer (content: NaCl, KCl, 
CaCl2_2H2O, MgCl2_6H2O, NaHCO3, NaH2PO4_H2O, glucose) containing 10% saccharose 
for 12 h, before being embedded into the paraffin wax. Thin sections (5 µm) of the paraffin 
blocks were cut, which were then stained with haematoxylin and eosin (H&E) for routine 
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morphological evaluation. The Biotin–Streptavidin biochemical method was used for im-
munohistochemistry (IMH) to detect various immunohistochemical markers (Table 1). 
Table 1. Description and characteristics of the primary antibodies. 
Primary Antibody * Antibody Characteristics ** Clone Dilution Catalogue No. Manufacturer 
Ki-67 Monoclonal rabbit AB against human AG SP6 1:100 1325506A Cell Marque (USA) 
IL-1α Polyclonal rabbit AB against human AG - 1:100 orb308737 Biorbyt (UK) 
IL-10 Polyclonal rabbit AB against human AG - 1:100 250713 Abbiotec (USA) 
VEGF Polyclonal rabbit AB against human AG - 1:100 orb191500 Biorbyt (UK) 
PGP 9.5 Polyclonal rabbit AB against human AG - 1:100 439273A Invitrogen (USA) 
EGFR Monoclonal mouse AB against human AG 0.N.26 1:100 sc-71034 Santa Cruz (USA) 
* Abbreviations: Ki-67—marker of proliferation KI67; IL-1α—interleukin-1α; IL-10—interleukin-10; VEGF—vascular en-
dothelial growth factor; PGP 9.5—protein gene product 9.5 and EGFR—epidermal growth factor receptor. ** Abbrevia-
tions: AB, antibody; AG, antigen. 
Negative and positive controls were included for all antibodies to avoid background 
staining and non-specific binding of secondary antibodies. For negative controls, primary 
antibodies were not added (water controls), thereby obtaining slides with no staining. Tis-
sues known to contain molecular factors, either from the manufacturer’s recommenda-
tions or from previous studies conducted at the Department of Morphology, RSU, were 
used as positive controls. 
2.4. TUNEL Reaction 
The detection of apoptotic cells was carried out using terminal deoxynucleotidyl 
transferase dUTP nick end labelling (TUNEL). It was performed using a standard in situ 
cell death detection kit, POD cat. no 11684817910, manufactured by Roche Diagnostics, in 
a working dilution of 1:10 [26]. 
2.5. Immunohistochemistry Semi-Quantification and Visualization 
The slides were analysed by light microscopy by two independent morphologists 
using the previously described semi-quantitative method [27]. The results were evaluated 
by grading the appearance of positively stained cells in the visual field (Table 2). For a 
visual illustration (microphotographs), Leica DC 300F digital camera and image pro-
cessing and analysis software, Image-Pro Plus (Media Cybernetics, Inc., Rockville, MD, 
USA) were used. 
Table 2. Description of the semi-quantitative method used in the present study. 
Grade Assigned Interpretation 
0 No positive structures 
0/+ Occasionally positive structures 
+ Few positive structures 
+/++ Few to moderate positive structures 
++ Moderate positive structures 
++/+++ Moderate to numerous positive structures 
+++ Numerous positive structures 
+++/++++ Numerous to abundant positive structures 
++++ Abundant positive structures 
2.6. Statistical Analysis 
Data processing was performed using the SPSS software v22.0 (IBM Company, Chi-
cago, IL, USA). Spearman’s rank correlation coefficient was used to determine correlations 
between factors, where r = 0–0.2 was assumed as a very weak correlation, r = 0.2–0.4 a 
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weak correlation, r = 0.4–0.6 a moderate correlation, r = 0.6–0.8 a strong correlation, and r 
= 0.8–1.0 a very strong correlation. To analyse the control group versus patient data, the 
Mann–Whitney U test was used. The level of significance for tests was chosen as 5% (p-
value < 0.05). 
3. Results 
3.1. General Appearance of the Vocal Noduli Tissue 
All vocal nodules were covered by stratified squamous epithelium and showed no-
table basal cell hyperplasia and vacuolized epitheliocytes (Figure 1A). Additionally, the 
basal membrane showed thickening, although the sub-epithelium demonstrated non-ho-
mogenous distribution of inflammatory cells, oedema, fibrotic tissue, and neoangiogenesis 
(Figure 1B). In tissue material from two patients, large cysts were visualized in the sub-
epithelial layers (Figure 1C). 
 
Figure 1. Microphotographs of routinely stained vocal noduli tissue using haematoxylin and eosin (H&E) staining. Red 
star indicates epithelial layer while green star indicates subepithelial layers. (A) Vacuolization of the epithelial cells is seen 
(yellow arrow) along with subepithelial infiltration of inflammatory cells (blue arrow); (B) Basal cell hyperplasia and 
thickened basal membrane in vocal noduli can be visualized (yellow arrow) and (C) Cyst with partially dendritic material 
of vocal noduli was seen in two patients (yellow arrow). Original magnification, 200×. 
3.2. Vocal Noduli Showed Significantly Increased Epithelial Proliferation 
Ki-67, the marker for proliferation, showed the presence of a moderate number of 
positive proliferating basal epitheliocytes (++) in the vocal noduli tissue, whilst the con-
trols did not express the marker at all (0–0/+) (Figure 2A,B). Additionally, the difference 
between vocal noduli tissue and controls was found to be statistically significant (p = 
0.0003; Table 3). 
Table 3. Summary table of results obtained from immunohistochemistry (IHC). 
Patient No. Sex Age Ki-67 TUNEL EGFR 
VEGF IL-1α 
IL-10 PGP 9.5 
Epi Endo Epi C.T. 
1 F 7 + +++ ++/+++ ++ +++ +++ ++ 0 0/+ 
2 F 18 + ++ ++ ++/+++ +++ +++ ++ 0 +/++ 
3 F 28 ++ ++/+++ +++ +++ ++ +++ +++ + +/++ 
4 F 32 ++ ++++ ++/+++ +++ ++ +++ +++ ++ ++ 
5 F 32 +/++ ++/+++ ++ +++ +++ +++/++++ +++ 0/+ +/++ 
6 F 42 +++ ++++ ++++ +++ +++ +++ +++ ++ 0/+ 
7 F 43 +/++ +++ ++ ++ ++ +++ +++/++++ 0 0/+ 
8 F 45 +/++ +++ +++/++++ +++ +++ +++ ++/+++ 0 + 
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9 F 55 ++ +++ +++ ++ ++ +++ +++ + + 
10 F 56 ++ +++ +++ +++ +++ +++ +++ + ++ 
Avg. Vocal Noduli Tissue ++ +++ +++ +++ ++/+++ +++ +++ Var 0 to ++ 
Var 
0/+ to ++ 
Avg. Control Tissue 0/+ +/++ ++ 0  0/+ 0 0/++ +/++ + 
Difference (p value) 0.0003 ** 0.0006 ** 0.005 ** 0.0003 ** 0.0003 ** 0.0003 ** 0.0003 ** 0.050 0.091 
** Statistically significant difference between control and vocal noduli tissue (p < 0.05; Mann–Whitney U test). The interpretation scale 
for the semi-quantitative scale is provided in Table 2; Abbreviations—Ki-67—marker of proliferation Ki-67; TUNEL—terminal de-
oxynucleotidyl transferase dUTP nick end labelling; EGFR—epidermal growth factor receptor; VEGF—vascular endothelial growth 
factor; IL-1α—interleukin-1α; IL-10—interleukin-10; PGP 9.5—protein gene product 9.5; Var—variable expression; Epi—epithelial 
tissue; Endo—endothelium/blood vessels and C.T.—connective tissue or subepithelial layer. 
 
Figure 2. Immunohistochemical assessment of epithelial proliferation, apoptosis, and growth in the vocal noduli and con-
trol tissue. Red star indicates epithelial layer while green star indicates subepithelial layers. (A) Moderate number of Ki-
67 positive basal epitheliocytes in the epithelial layer of a patient with vocal noduli. Original magnification, 400×; (B) No 
Ki-67 immunopositive structures are visualized in the control tissue. Original magnification, 200×; (C) Numerous apop-
totic epitheliocytes are seen in the tissue from patient with vocal noduli using TUNEL reaction. Original magnification, 
400×; (D) There is absence of apoptotic cells in the epithelium of vocal cord tissue obtained from controls using TUNEL 
reaction. Original magnification, 200×; (E) Numerous EGFR positive epitheliocytes along with connective tissue cells are 
visualized in the vocal noduli tissue. Original magnification, 250× and (F) Moderate number of EFGR positive connective 
tissue cells but no positive epitheliocytes can be seen in the control tissue. Original magnification, 250×. 
3.3. Vocal Noduli Showed Significantly Increased Epithelial Apoptosis 
TUNEL reaction was used to visualize the presence of apoptosis in the tissue sam-
ples. In the vocal noduli tissue, numerous cells were observed undergoing programmed 
cell death (+++) compared with only a few to moderate (+/++) number of cells in the epi-
theliocytes from the control tissue (Figure 2C,D). The difference again, was found to be 
statistically significant (p = 0.0006; Table 3). 
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3.4. Vocal Noduli Showed Significantly Increased Epithelial Cellular Growth 
EGFR was used to understand the differences in the cellular growth (hyperplastic 
changes). As expected, EGFR staining revealed numerous positive (+++) epithelial cells in 
vocal noduli tissue, whilst in controls, the staining showed positivity only in moderate 
number (++) of cells (Figure 2E,F). The difference was found to be statistically significant 
(p = 0.005; Table 3). 
3.5. Vocal Noduli Tissue Showed Significant Ischaemic Compensatory Changes 
VEGF, an indirect marker of tissue hypoxia, was used to look for tissue stress and 
the associated compensatory changes (neoangiogenesis). Numerous VEGF immunoreac-
tive cells were observed (+++) in vocal noduli tissue, but an absence of immunoreactivity 
was noted in the control tissue (0–0/+). Such changes were visible in both epithelium and 
blood vessels (Figure 3A,B). Statistically, the difference in both endothelium and epithe-
lium was found to be significant (p = 0.0003; Table 3). 
 
Figure 3. Immunohistochemical assessment of tissue ischaemia, and inflammatory environment in the vocal noduli and 
control tissue. Red star indicates epithelial layer while green star indicates subepithelial layers. (A) Numerous positive 
VEGF positive cells were observed in both epithelium and blood vessels of vocal noduli tissue. Original magnification, 
400×; (B) Few positive endotheliocytes in the blood vessel of vocal cords show VEGF positivity in the control tissue. Orig-
inal magnification, 250×; (C) Numerous IL-1α immunopositive epitheliocytes and connective tissue cells in vocal noduli 
tissue. Original magnification, 250×; (D) Few IL-1α positive macrophages are seen in the control tissue. Original magnifi-
cation, 250×; (E) Moderate IL-10 immunopositive epitheliocytes are seen in the vocal noduli tissue. Original magnification, 
200× and (F) Weakly stained IL-10 positive epitheliocytes and connective tissue cells (mainly macrophages) in the vocal 
cords from controls. Original magnification, 200×. 
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3.6. Vocal Noduli Showed Presence of Pro-Inflammatory Environment 
IL-1α, a pro-inflammatory cytokine and IL-10, an anti-inflammatory cytokine, were 
checked to assess the tilt in the balance of inflammatory environment. We observed nu-
merous IL-1 positive (+++) epithelial and connective tissue cells in the vocal noduli tissue 
whilst the controls demonstrated only few positive cells (0/+). In fact, in controls these few 
positive cells were tissue macrophages seen in the connective tissue (Figure 3C,D). The 
difference between control and vocal noduli tissue was statistically significant (p = 0.0003; 
Table 3). For IL-10, marked variation amongst vocal noduli samples was noted with an 
average of moderate number of positive cells (Figure 3E,F). In the control tissue, the ex-
pression of IL-10 was rather more homogenous and consistent (+/++). There was no statis-
tically significant difference noted in expression of IL-10 (p = 0.050; Table 3). These find-
ings indicate a shift in the balance towards a pro-inflammatory environment. 
3.7. No Significant Difference in Neural Innervation Was Found in Vocal Noduli 
PGP 9.5, a marker for neurons and neuroendocrine cells in non-neoplastic tissue, 
showed variable expression in vocal noduli tissue ranging from complete absence to 
presence of moderate immunoreactive nerve fibres (0 to ++). In the controls, few immuno-
positive neuroendocrine cells in the epithelium (+) and few nerve fibres in the subepithe-
lium (+) were noted (Figure 4A,B). The difference was found to be statistically insignifi-
cant (p = 0.091; Table 3). 
 
Figure 4. Immunohistochemical assessment of immunoreactive innervation in the vocal noduli and control tissue. Red 
star indicates epithelial layer while green star indicates subepithelial layers. (A) Few PGP 9.5 immunopositive neuroen-
docrine cells in the epithelium and fine nerve fibres in connective tissue can be visualized in the vocal noduli tissue. Orig-
inal magnification, 200× and (B) Few PGP 9.5 immunopositive nerves in the subepithelium, mainly seen amongst the 
smooth muscle bundles of the blood vessel in the control vocal cord tissue. Original magnification, 200×. 
3.8. Correlation Analysis between Different Immunohistochemical Markers 
A significantly strong correlation was observed between expression of Ki-67 and 
presence of apoptosis (ρ = 0.888, p < 0.001), VEGF (ρ = 0.884, p < 0.001), EGFR (ρ = 0.839, p 
< 0.001), and IL-1 in both epithelial (ρ = 0.834, p < 0.001) and connective tissue (ρ = 0.899, 
p < 0.001) in the vocal noduli tissue (Table 4). Furthermore, a significantly strong positive 
correlation was seen between apoptosis marker and VEGF (ρ = 0.802, p < 0.001), and IL-1 
in both epithelial (ρ = 0.786, p < 0.001) and connective tissue (ρ = 0.820, p < 0.001) in the 
vocal noduli tissue. 
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Table 4. Correlation analysis of the vocal noduli tissue factors which were found to have positive and significant (p < 0.05) 
correlations. 
Strength of Correlation Factor 1 ** Factor 2 ** Rho (ρ) p Value 
Strong positive correlation (ρ = 0.7–0.9) 
Ki-67 TUNEL 0.888 <0.001 
Ki-67 VEGF 0.884 <0.001 
Ki-67 EGFR 0.839 <0.001 
Ki-67 IL-1α (Epithelium) 0.834 <0.001 
Ki-67 IL-1α (Connective tissue) 0.899 <0.001 
TUNEL VEGF 0.802 <0.001 
TUNEL IL-1α (Epithelium) 0.786 <0.001 
TUNEL IL-1α (Connective tissue) 0.820 <0.001 
TUNEL EGFR 0.753 <0.001 
EGFR VEGF 0.750 <0.001 
IL-1α (Epithelium) IL-1α (Connective tissue) 0.868 <0.001 
VEGF IL-1α (Epithelium) 0.889 <0.001 
VEGF IL-1α (Connective tissue) 0.745 <0.001 
Moderate positive correlation 
(ρ = 0.5–0.7) 
Ki-67 PGP 9.5 0.504 0.032 
EGFR IL-1α (Epithelium) 0.625 0.005 
EGFR IL-1α (Connective tissue) 0.611 0.007 
VEGF PGP 9.5 0.614 0.006 
Weak positive correlation (ρ = 0.3–0.5) IL-1α (Epithelium) PGP 9.5 0.469 0.049 
** Abbreviations: Ki-67—proliferation marker Ki-67, IL-1α-Interleukin-1α, VEGF—vascular endothelial growth factor, 
PGP 9.5—protein gene product 9.5, EGFR—epidermal growth factor receptor and TUNEL—terminal deoxynucleotidyl 
transferase dUTP nick end labelling. 
TUNEL positive structures also strongly correlated with EGFR (ρ = 0.753, p < 0.001), 
whilst EGFR expression correlated strongly with the expression of VEGF (ρ = 0.750, p < 
0.001). There was a strong positive correlation between epithelial IL-1 and connective 
tissue IL-1 (ρ = 0.868, p < 0.001) expression. VEGF and IL-1-containing epitheliocytes (ρ = 
0.889, p < 0.001) and IL-1 positive connective tissue cells (ρ = 0.745, p < 0.001) also showed 
significantly strong positive correlation. 
Finally, we observed a moderate positive correlation between cellular expression 
of Ki-67 and PGP 9.5 nerves (ρ = 0.504, p = 0.032) and expression of VEGF and PGP 9.5 (ρ 
= 0.614, p = 0.006). On the other hand, EGFR moderately correlated with IL-1 in epithelial 
(ρ = 0.625, p = 0.005) and IL-1 in connective tissue (ρ = 0.611, p = 0.007). In our present 
study, we also observed a weak yet significant correlation between expression of epithe-
lial IL-1 and PGP 9.5 nerves (ρ = 0.469, p = 0.049). 
4. Discussion 
In the present study, we observed that vocal cord noduli demonstrated a significant 
and prominent increase in epithelial EGFR, VEGF, IL-1 expression, along with an increase 
in the global prevalence of epithelial apoptotic cells, a phenomenon not observed in the 
tissue samples from healthy human vocal cords. Furthermore, in the abundance of inflam-
matory cells in the subepithelium, notable expression of IL-1 and VEGF, and the elucida-
tion of strong correlations between them suggest a possible connection between persisting 
inflammatory changes in the vocal noduli tissue, as evidenced by localized tissue hy-
poxia/ischemia. Indeed, not only does the repeated stress and trauma, resulting from vo-
cal cord overuse lead to a formation of a hypoxic environment, but also the release of pro-
inflammatory cytokines can initiate/maintain the development of such benign vocal cord 
structures. This is supported by evidence from other researchers, who reported that the 
hypoxia inducible factor-1α (HIF-1α) and VEGF are notably elevated in the vocal polyp 
tissue. The authors had hypothesised that this increased level of HIF-1α is a result of over-
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vibration of the vocal cord, which induced hypoxia and was followed by increased ex-
pression of VEGF [13]. 
The significance of closely related VEGF-EGFR intercorrelations and their activities 
were also described by Guo et al., who pointed out that the inhibition of this interaction 
may play a crucial role in some tumour proliferation signal pathway blockage [28], as the 
VEGFR-EGFR relation directly influences the inhibition of cell invasion and migration 
during the experimental conditions of wound healing. Additionally, IL-1 is the most 
prominent interleukin in acute and chronic inflammation settings which is released in case 
of endothelial injury/stimulation. Apart from vascular injury, stimulation of IL-1 by the 
expression of VEGF in our patients is another factor to consider in the etiopathology of 
vocal cord noduli [29]. We hypothesize that IL-1 mediated inflammation can aggravate 
the already described nodular epithelial hyperplasia, basement membrane thickening, oe-
dema, and fibrotic changes [16]. These processes can accelerate scar formation, extra col-
lagen deposition and maintenance/stimulation of vocal cord nodule formation. 
The routine morphological findings of non-specific changes in the epithelial tissue 
(basal cell hyperplasia, vacuolization), together with the dominance of the above-men-
tioned upregulated expression of EGFR, IL-1 and Ki-67, and global apoptosis in the vocal 
nodule’s epithelium, suggest epithelium cells to be more intensively affected in the case 
of vocal abuse. The close correlations found between these factors highlight their possible 
role into the modulation of each other’s functions. A similar finding was observed in the 
animal vocal cord undergoing regeneration of its epithelium during the acute phase of 
injury [30]. A time-dependent secretion of the proliferation marker, Ki-67, growth factors 
EGF and TGFβ1, as well as activation of the EGFR was observed in the animal vocal cord 
[30]. The authors proposed the epitheliocytes activity in the wound healing process was 
guided by autocrine and paracrine signalling pathway during wound healing. We specu-
late on the similar lines, that in the vocal noduli of our patients, the epithelium signifi-
cantly expresses different tissue factors in response to the regular phono-trauma and per-
sistent inflammatory environment. 
The expression of the human Ki-67 is closely associated with cell proliferation. Stud-
ies on vocal polyps have shown that an increase in and correlation of Ki-67, EGFR, and 
some other factors immunohistochemically in epithelium may change the vocal cord re-
gion. Subsequently, high-grade dysplasia also shows statistically higher expression and 
immunoreactivity of Ki-67, whereas low-grade dysplasia demonstrates the opposite re-
sults [24,31]. This indicated a positive expression grade of Ki-67 in vocal cords leucoplakia 
with epithelial dysplasia as a valuable marker for the evaluation, diagnosis, and prognosis 
of precancerous lesions in the vocal cords. We report here an increase in Ki-67 positive 
cells and thus, stimulation of epithelial proliferation in benign vocal cord noduli that oc-
curs probably in response to specific stimulation of other intra-epithelial factors such as 
EGFR, VEGF, and IL-1. Intensive apoptosis was also seen in our patient’s vocal noduli 
epithelium. Taking into the account the close correlations between the TUNEL, VEGF, IL-
1, and EGFR positive cells, we suppose the direct complex stimulation of ischemia, pro-
inflammatory cytokines, and cellular proliferation inducers on the acceleration of pro-
grammed cell death in the vocal cord noduli. 
Apoptosis is considered an organized/programmed pathway for cellular degrada-
tion for several reasons. Some evidence of apoptosis in the vocal fold epithelium has been 
reported in the past, described especially in response to biomechanical trauma which 
caused a rise in apoptotic rate ultra-structurally in the vocal fold epithelium after experi-
mental vibration of rabbit vocal folds [10]. However, some contrary data revealing no sig-
nificant impact of the biomechanical strength on the vocal cord cellular apoptosis has been 
reported as well. Human vocal cord vibrations were found to not alter the apoptosis rate 
after the influence of intense vibration and strain [32], which leaves the question about the 
origin of apoptosis in the vocal cords partially open. Most likely, in our opinion, the pro-
grammed cell death mechanisms are more complex and under multiple regulatory pro-
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cesses. So, the pathogenesis of vocal pathology may be associated with cell signalling mis-
communication that involves apoptosis and/or irregularities in apoptosis may eventually 
evolve into epithelial hyperplasia and/or benign nodular formations [33,34]. The abnor-
mal apoptosis might also be connected to the changes in the epithelial tight junctions that 
leads to changes in the phenotype of the epithelial cells following their irregular removal 
[35]. 
Variability in the expression of the neuropeptide-containing innervation represented 
by PGP 9.5 and of anti-inflammatory cytokine IL-10 in vocal noduli tissue did not differ 
from their expression in healthy vocal cord tissue significantly, thereby allowing us to 
exclude their role from the pathogenesis of vocal noduli formation. However, the varia-
tions and even absence of IL-10 expression in the patient’s vocal noduli does not neces-
sarily remove the question about the suppression of the main anti-inflammatory cytokine 
in the vocal noduli tissue and probably needs a more personalized approach to the anal-
ysis of the palisade of pro-, regulatory-, and anti-inflammatory cytokines to explain their 
varied role and function in the persistent inflammation in these benign structures of the 
vocal cords. 
The structural changes in the vocal noduli tissue of the patients in the age range from 
17 to 56 years are quite similar thereby implying no significant effects of ageing related 
changes. The tissues gave similar response to different environmental irritants, and we 
speculate that this morphological phenomenon takes place also in the vocal cords. Addi-
tionally, in the literature only the vocal cord atrophy is described in geriatric population 
which shows a different morpho-pathogenesis when compared with the benign vocal box 
structures [36,37]. 
With respect to the involvement of proliferation markers, apoptosis, specific cyto-
kines, and neo-angiogenetic factors in the morpho-pathogenesis of vocal noduli described 
by us, there are some limitations of our work which should be mentioned for future re-
search. An important issue might be the tissue factor concentration revealed by ELISA 
and the evaluation of some gene/gene or protein/protein impact in the develop-
ment/maintenance of vocal noduli. Additionally, a comparison of childhood (before the 
puberty age) and very old age vocal benign structures should be done to clarify the pos-
sible impact of aging on these structures. Nonetheless, this last limitation is rather very 
strictly limited due to the ethical considerations and due the difficulty in accessing such 
tissue material. Finally, the relatively small number of participants from the same gender 
included in the present study may limit our capacity to generalize our findings clinically. 
However, it is important to take into notice that the present study aimed to elucidate the 
patho-morphogenesis of vocal noduli at a cellular and morphological level. Future studies 
with a bigger study group and including both genders should be undertaken to fully un-
derstand the interplay of various underlying factors in the aetiology of vocal noduli for-
mation and maintenance. 
5. Conclusions 
The significantly upregulated expression of Ki-67 and EGFR in the epithelial tissue 
suggests the intensification of cellular growth and proliferation, leading to hyperplastic 
changes in the tissue structure. Such changes occur in the presence of a persistent pro-
inflammatory environment (significantly increased expression of IL-1α) coupled with as-
sociated ischemic changes which triggers a compensatory reaction from epithelium and 
endothelium alike. This causes the upregulation of angiogenesis (significantly increased 
VEGF expression) in the vocal noduli tissue. 
Intensification of apoptosis and its strong correlation with proliferation, ischemia, 
and inflammatory factors highlight the underlying complex interactions between various 
mechanisms on a cellular and tissue level, which occur during the morpho-pathogenesis 
of vocal nodules and most likely are responsible for the maintenance of their formation. 
A similar expression of anti-inflammatory cytokine IL-10 and neuropeptide-containing 
innervation marker PGP 9.5 in the healthy and vocal noduli tissue eliminates the “acute” 
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participation of these markers in the morpho-pathogenesis of the vocal nodules. Finally, 
the morphology of vocal nodules does not seem to depend on the age of the patient, at 
least in the 17–56 years age group. 
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